Liquidia plunges after court ruling in United Therapeutics patent fight (update)

Summary

Liquidia experienced a significant stock decline following an unfavorable court ruling in its patent dispute with United Therapeutics. The specific details of the patent fight and ruling outcome are not provided in the article snippet.